Chinese english Japanese Germany Korea

SNDX-5613

SNDX-5613 Structure
CAS No.
2169919-21-3
Chemical Name:
SNDX-5613
Synonyms
SNDX-5613;Revumenib;SNDX-5613 SNDX5613;acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid;N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide;Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-
CBNumber:
CB47244410
Molecular Formula:
C32H47FN6O4S
Molecular Weight:
630.82
MOL File:
2169919-21-3.mol
Modify Date:
2024/7/2 8:55:09
Request For Quotation

SNDX-5613 Properties

Boiling point 739.1±70.0 °C(Predicted)
Density 1.28±0.1 g/cm3(Predicted)
solubility DMSO:30.0(Max Conc. mg/mL);47.56(Max Conc. mM)
pka 11.10±0.40(Predicted)
form Solid
color White to off-white

SNDX-5613 Preparation Products And Raw materials

Raw materials

Preparation Products

SNDX-5613 Suppliers

Global( 45)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32760 60 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Wuhan Nutra Biotechnology Co.,Ltd +8617786394783 China 300 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
Nantong HI-FUTURE Biology Co., Ltd. +undefined18051384581 China 3136 58 Inquiry
Wuhan Topule Biopharmaceutical Co., Ltd +8618327326525 China 8474 58 Inquiry
Aladdin Scientific +1-+1(833)-552-7181 United States 57511 58 Inquiry
Suzhou ARTK Medchem Co., Ltd. +8618168183658 China 39009 58 Inquiry
InvivoChem 13549236410 China 6749 58 Inquiry
Wuhan Topule +86-02787215551 +86-19945035818 China 8213 58 Inquiry
Supplier Advantage
ATK CHEMICAL COMPANY LIMITED 60
TargetMol Chemicals Inc. 58
Wuhan Nutra Biotechnology Co.,Ltd 58
Zhejiang J&C Biological Technology Co.,Limited 58
Nantong HI-FUTURE Biology Co., Ltd. 58
Wuhan Topule Biopharmaceutical Co., Ltd 58
Aladdin Scientific 58
Suzhou ARTK Medchem Co., Ltd. 58
InvivoChem 58
Wuhan Topule 58

2169919-21-3(SNDX-5613)Related Search:

SNS-062 PF-04929113 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide hydrochloride N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea
SNDX-5613 acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)- SNDX-5613 SNDX5613 Revumenib N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide 2169919-21-3